Exabis Library
Welcome to the e-CCO Library!
P084: Response to appendectomy in refractory Ulcerative Colitis appears based on two distinct inflammatory phenotypes
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P084: Secreted inflammatory protein profiles following treatment of ex-vivo human Ulcerative Colitis and Crohn’s Disease explants with licenced biologic therapies
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P085 Deep profiling of the circulating immune cell landscape in inflammatory bowel disease by mass cytometry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P085: Altered proportions of myeloid and plasmacytoid dendritic cells in children with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P085: Crohn’s disease patients under combined therapy with Azathioprine and Infliximab present persistent inflammation together with a counter regulatory response during clinical disease remission
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P085: Expression profiling of Wnt pathway genes in colon biopsies of patients with Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P085: Gut microbiota profile changes in patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P085: Paneth cells translate dietary lipid exposure into gut inflammation
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P085: Safety analysis of vedolizumab: a reproductive toxicology study in rabbits
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P085: The effect of vitamin D on macrophage function and polarization in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P086 Identification of constitutive modifications in plasma cells and B lymphocytes in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P086: Eukaryotic microbial dysbiosis in treatment-naïve patients with newly diagnosed Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P086: Glycosylation of T-cells as a new molecular biomarker in inflammatory bowel disease: an opportunity for new therapeutic strategies
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P086: MMP-12, a novel mediator of nociception in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P086: Mucosal microbiota modulate host intestinal immune signatures in Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P086: Non-enzymatic serum antioxidant capacity is diminished in inflammatory bowel disease and is associated with severity of inflammation in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P086: Sirtuin 7 inhibitor attenuates colonic mucosal immune activation in mice–potential therapeutic target in Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P086: Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon immune dysregulation and intestinal permeability in a stress-induced colonic inflammation
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P087 Biomarkers of elastin degradation differentiate between clinically inactive and active disease in ulcerative colitis patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P087: A novel OGR1 (GPR68) inhibitor attenuates inflammation in a murine model of Acute Colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM